Akèy › Kansè poumon › Minnesota › Bloomington
Etid klinik pou Kansè poumon nan Bloomington, MN
10 etid pou Kansè poumon ap chèche patisipan nan sit nan ak bò kote Bloomington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Ap rekriteFaz 3
- Fairview Southdale Hospital, Edina · 4 mi lwen
- Minnesota Oncology - Edina, Edina · 4 mi lwen
- Minnesota Oncology - Burnsville, Burnsville · 5 mi lwen
- ak 1 plis
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Fairview Southdale Hospital, Edina · 4 mi lwen
- Minnesota Oncology - Edina, Edina · 4 mi lwen
- Minnesota Oncology - Burnsville, Burnsville · 5 mi lwen
- ak 2 plis
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Ap rekriteFaz 3
- Fairview Southdale Hospital, Edina · 4 mi lwen
- Minnesota Oncology - Burnsville, Burnsville · 5 mi lwen
- Saint Francis Regional Medical Center, Shakopee · 12 mi lwen
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Ap rekriteFaz 3
- Fairview Southdale Hospital, Edina · 4 mi lwen
- Minnesota Oncology - Edina, Edina · 4 mi lwen
- Minnesota Oncology - Burnsville, Burnsville · 5 mi lwen
- ak 1 plis
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Ap rekriteFaz 3
- Fairview Southdale Hospital, Edina · 4 mi lwen
- Minnesota Oncology - Edina, Edina · 4 mi lwen
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Minnesota Oncology Hematology, P.A., Edina · 4 mi lwen
- Minnesota Oncology Hematology, P.A., Burnsville · 5 mi lwen
- Minnesota Oncology Hematology, P.A., Chaska · 15 mi lwen
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Ap rekriteFaz 3
- M Health Fairview Cancer Clinic-Edina, Edina · 4 mi lwen
- Minnesota Oncology Hematology PA, Edina · 4 mi lwen
- Minnesota Oncology Hematology, PA, Burnsville · 5 mi lwen
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Fairview Southdale Hospital, Edina · 4 mi lwen
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2/3
- Fairview Southdale Hospital, Edina · 4 mi lwen
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Ap rekriteEtid obsèvasyon
- Fairview Southdale Hospital, Edina · 4 mi lwen
- Minnesota Oncology - Burnsville, Burnsville · 5 mi lwen
- Saint Francis Regional Medical Center, Shakopee · 12 mi lwen
Etid Kansè poumon nan lòt vil
- Houston, TX78 etid
- Boston, MA62 etid
- New York City, NY60 etid
- Los Angeles, CA45 etid
- Washington, DC41 etid
- Arlington, VA41 etid
- Chicago, IL41 etid
- Nashville, TN40 etid
- Baltimore, MD40 etid
- St. Louis, MO39 etid
- Columbus, OH37 etid
- Philadelphia, PA36 etid
Lòt etid nan Bloomington
- Kansè Poumon ki pa ti selil10 etid
- Kansè kolorektal7 etid
- Kansè pwostat6 etid
- Kansè renn (Kasinom selil renn)6 etid
- Leksemi mieloïd egi6 etid
- Kansè vejik5 etid
- Kansè nan tete5 etid
- Kansè Endomèt4 etid
- Melanom4 etid
- Kansè kolon4 etid
- Adenokasinom Ezofajyen3 etid
- Kansè Metastatik3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.